Recently, our research group has integrated 33 cancer species confirmed that ZIC2 is highly expressed in multiple tumors and had a significant correlation with tumor progression and survival of patients especially in renal cell carcinoma 9. This evidence concerns the gene ZIC2 and hereditary clear cell renal cell carcinoma.